全体要約
2022年の動物再生医療市場規模は2億6030万米ドルで、2029年には6億1540万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率（CAGR）は13.1%です。
動物再生医療は、骨関節炎や軟部組織損傷などの整形外科的疾患の治療に効果的であり、手術や薬物療法の代替手段として利用されています。
動物再生医療では、間葉系幹細胞（MSCs）が重要な役割を果たし、自己複製や異なる細胞型への分化が可能です。市場は、血小板豊富血漿（PRP）、幹細胞治療などの製品タイプや、獣医病院・クリニック、獣医研究機関などの用途に分かれています。地域別では、アメリカ、アジア太平洋、ヨーロッパ、中東・アフリカが含まれます。
関連する質問
260.3百万米ドル（2022年）
13.1%（2023年から2029年）
ACell Inc. (Integra LifeSciences), Animal Cell Therapies, Inc., Ardent, Boehringer Ingelheim International GmbH, Cell Therapy Sciences, Dechra, Enso Discoveries, South Paws Veterinary Surgical Specialists, Veterinary Specialty Center, Vetbiologics, Vetherapy, VetStem, Inc., Zoetis
細胞ベースの治療法の利用, 整形外科疾患の治療効果, 外科的治療の代替手段としての利用
概要
再生医療療法は、さまざまな疾患の治療のために、ヒトおよび獣医療の両方で人気が高まっています。急速に発展している獣医再生医療の分野では、血清や骨などの生細胞や組織が使用され、病気や損傷した組織や臓器の回復が期待されています。最近の研究では、椎間板症や軟部組織の損傷を含む、伴侶動物のさまざまな整形外科的障害の管理において効果的であることが示されています。再生医療は、外科的治療、薬物療法、リハビリテーション治療の代替手段として、または状態や怪我の治療に対する多様なアプローチとして、ますます利用されています。
再生医療は、細胞ベースの治療法を含むさまざまなアプローチを使用して、病気や損傷を受けた細胞、組織、および臓器の正常な機能を回復させることを目的としています。獣医学の分野では、再生医療は間葉系幹細胞（MSC）の使用と強く関連しており、これらは身体の修復システムに属し、自己複製能力を持ちながら、さまざまな細胞タイプに分化できる多能性前駆細胞と定義されています。
LPI (LP Information)の最新の調査報告書「獣医再生医療業界予測」では、過去の販売実績を調査し、2022年の世界の獣医再生医療販売の総額をレビューしています。また、2023年から2029年までの地域別および市場セクター別の獣医再生医療販売予測に関する包括的な分析を提供。地域、市場セクター、サブセクター別に分解された獣医再生医療の販売に関し、この報告書は世界の獣医再生医療業界について、数百万USドル単位の詳細な分析を提供します。
このインサイトレポートは、世界の獣医再生医療の状況に関する包括的な分析を提供し、製品のセグメンテーション、企業の形成、収益、市場シェア、最新の開発、およびM&A活動に関連する主要トレンドを強調しています。このレポートはまた、獣医再生医療ポートフォリオと能力、市場参入戦略、市場の地位、地理的なフットプリントに焦点を当て、世界の獣医再生医療市場が加速する中で、これらの企業の独自の位置をよりよく理解するために、世界の主要企業の戦略を分析しています。
このインサイトレポートは、獣医再生医療のグローバルな展望を形成する主要な市場動向、ドライバー、および影響要因を評価し、タイプ、用途、地理、および市場規模別に予測を分解して、新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性的および定量的市場インプットに基づく透明な方法論を用いたこの研究予測は、グローバルな獣医再生医療の現在の状態と将来の軌道に対する非常に詳細な見解を提供します。
このレポートは、製品タイプ、アプリケーション、主要プレーヤー、主要地域および国別の獣医再生医療市場の包括的な概要、市場シェアおよび成長機会を提示します。
市場セグメンテーション：
タイプ別のセグメンテーション
多血小板血漿（PRP）
幹細胞治療
その他
アプリケーションによるセグメンテーション
獣医病院/クリニック
獣医研究所
この報告書は地域別に市場を分割しています：
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選定されています。
ACell Inc.（インテグラ・ライフサイエンシズ）
アニマルセルセラピー株式会社
熱心な
ベーリンガーインゲルハイム社
細胞療法科学
デクラー
エンソ・ディスカバリーズ
サウスパウズ獣医外科専門家
獣医専門センター
獣医生物製品
ベータセラピー
ベットステム株式会社
ゾエティス
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの動物再生医療市場規模、（2018年～2029年）
2.1.2 動物再生医療市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 動物再生医療セグメント、タイプ別
2.2.1 多血小板血漿(PRP)
2.2.2 幹細胞治療
2.2.3 その他
2.3 動物再生医療市場規模：タイプ別
2.3.1 動物再生医療市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの動物再生医療市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 動物再生医療セグメント、用途別
2.4.1 動物病院/クリニック
2.4.2 獣医学研究所
2.5 動物再生医療市場規模：用途別
2.5.1 動物再生医療市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの動物再生医療市場規模、市場シェア（用途別）（2018年～2023年）
3 動物再生医療市場規模：プレイヤー別
3.1 動物再生医療市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける動物再生医療市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける動物再生医療市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの動物再生医療市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 動物再生医療、地域別
4.1 動物再生医療市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける動物再生医療市場規模成長（2018年〜2023年）
4.3 APACにおける動物再生医療市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける動物再生医療市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける動物再生医療市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける動物再生医療市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける動物再生医療市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける動物再生医療市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける動物再生医療市場規模、地域別（2018年〜2023年）
6.2 APACにおける動物再生医療市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける動物再生医療市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの動物再生医療 国別（2018年～2023年）
7.2 ヨーロッパにおける動物再生医療市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける動物再生医療市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの動物再生医療 地域別（2018年～2023年）
8.2 中東・アフリカにおける動物再生医療市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける動物再生医療市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの動物再生医療市場、市場予測
10.1 グローバルの動物再生医療、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの動物再生医療、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの動物再生医療、市場予測
10.1.3 APACの動物再生医療、市場予測
10.1.4 ヨーロッパの動物再生医療、市場予測
10.1.5 中東・アフリカの動物再生医療、市場予測
10.2 アメリカズの動物再生医療、市場予測（国別）（2024年～2029年）
10.3 APACの動物再生医療、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの動物再生医療、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの動物再生医療、市場予測（地域別）（2024年～2029年）
10.6 グローバルの動物再生医療、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの動物再生医療、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 ACell Inc\. \(Integra LifeSciences\)
11.1.1 ACell Inc\. \(Integra LifeSciences\)：企業情報
11.1.2 ACell Inc\. \(Integra LifeSciences\)：動物再生医療分野の提供製品
11.1.3 ACell Inc\. \(Integra LifeSciences\)：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 ACell Inc\. \(Integra LifeSciences\)：主要事業概要
11.1.5 ACell Inc\. \(Integra LifeSciences\)：直近の展開
11.2 Animal Cell Therapies, Inc
11.3 Ardent
11.3.1 Ardent：企業情報
11.3.2 Ardent：動物再生医療分野の提供製品
11.3.3 Ardent：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Ardent：主要事業概要
11.3.5 Ardent：直近の展開
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH：企業情報
11.4.2 Boehringer Ingelheim International GmbH：動物再生医療分野の提供製品
11.4.3 Boehringer Ingelheim International GmbH：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Boehringer Ingelheim International GmbH：主要事業概要
11.4.5 Boehringer Ingelheim International GmbH：直近の展開
11.5 Cell Therapy Sciences
11.5.1 Cell Therapy Sciences：企業情報
11.5.2 Cell Therapy Sciences：動物再生医療分野の提供製品
11.5.3 Cell Therapy Sciences：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 Cell Therapy Sciences：主要事業概要
11.5.5 Cell Therapy Sciences：直近の展開
11.6 Dechra
11.6.1 Dechra：企業情報
11.6.2 Dechra：動物再生医療分野の提供製品
11.6.3 Dechra：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Dechra：主要事業概要
11.6.5 Dechra：直近の展開
11.7 Enso Discoveries
11.7.1 Enso Discoveries：企業情報
11.7.2 Enso Discoveries：動物再生医療分野の提供製品
11.7.3 Enso Discoveries：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Enso Discoveries：主要事業概要
11.7.5 Enso Discoveries：直近の展開
11.8 South Paws Veterinary Surgical Specialists
11.8.1 South Paws Veterinary Surgical Specialists：企業情報
11.8.2 South Paws Veterinary Surgical Specialists：動物再生医療分野の提供製品
11.8.3 South Paws Veterinary Surgical Specialists：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 South Paws Veterinary Surgical Specialists：主要事業概要
11.8.5 South Paws Veterinary Surgical Specialists：直近の展開
11.9 Veterinary Specialty Center
11.9.1 Veterinary Specialty Center：企業情報
11.9.2 Veterinary Specialty Center：動物再生医療分野の提供製品
11.9.3 Veterinary Specialty Center：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 Veterinary Specialty Center：主要事業概要
11.9.5 Veterinary Specialty Center：直近の展開
11.10 Vetbiologics
11.10.1 Vetbiologics：企業情報
11.10.2 Vetbiologics：動物再生医療分野の提供製品
11.10.3 Vetbiologics：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 Vetbiologics：主要事業概要
11.10.5 Vetbiologics：直近の展開
11.11 Vetherapy
11.11.1 Vetherapy：企業情報
11.11.2 Vetherapy：動物再生医療分野の提供製品
11.11.3 Vetherapy：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.11.4 Vetherapy：主要事業概要
11.11.5 Vetherapy：直近の展開
11.12 VetStem, Inc
11.13 Zoetis
11.13.1 Zoetis：企業情報
11.13.2 Zoetis：動物再生医療分野の提供製品
11.13.3 Zoetis：動物再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.13.4 Zoetis：主要事業概要
11.13.5 Zoetis：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
LPI (LP Information)' newest research report, the “Veterinary Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Veterinary Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Regenerative Medicine sales for 2023 through 2029. With Veterinary Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Regenerative Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Regenerative Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others
Segmentation by application
Veterinary Hospitals/Clinics
Veterinary Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Regenerative Medicine Market Size 2018-2029
2.1.2 Veterinary Regenerative Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Veterinary Regenerative Medicine Segment by Type
2.2.1 Platelet-Rich Plasma (PRP)
2.2.2 Stem Cell Therapy
2.2.3 Others
2.3 Veterinary Regenerative Medicine Market Size by Type
2.3.1 Veterinary Regenerative Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023)
2.4 Veterinary Regenerative Medicine Segment by Application
2.4.1 Veterinary Hospitals/Clinics
2.4.2 Veterinary Research Institutes
2.5 Veterinary Regenerative Medicine Market Size by Application
2.5.1 Veterinary Regenerative Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023)
3 Veterinary Regenerative Medicine Market Size by Player
3.1 Veterinary Regenerative Medicine Market Size Market Share by Players
3.1.1 Global Veterinary Regenerative Medicine Revenue by Players (2018-2023)
3.1.2 Global Veterinary Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Regenerative Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Veterinary Regenerative Medicine by Regions
4.1 Veterinary Regenerative Medicine Market Size by Regions (2018-2023)
4.2 Americas Veterinary Regenerative Medicine Market Size Growth (2018-2023)
4.3 APAC Veterinary Regenerative Medicine Market Size Growth (2018-2023)
4.4 Europe Veterinary Regenerative Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Veterinary Regenerative Medicine Market Size Growth (2018-2023)
5 Americas
5.1 Americas Veterinary Regenerative Medicine Market Size by Country (2018-2023)
5.2 Americas Veterinary Regenerative Medicine Market Size by Type (2018-2023)
5.3 Americas Veterinary Regenerative Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Regenerative Medicine Market Size by Region (2018-2023)
6.2 APAC Veterinary Regenerative Medicine Market Size by Type (2018-2023)
6.3 APAC Veterinary Regenerative Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Veterinary Regenerative Medicine by Country (2018-2023)
7.2 Europe Veterinary Regenerative Medicine Market Size by Type (2018-2023)
7.3 Europe Veterinary Regenerative Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Regenerative Medicine by Region (2018-2023)
8.2 Middle East & Africa Veterinary Regenerative Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Veterinary Regenerative Medicine Market Forecast
10.1 Global Veterinary Regenerative Medicine Forecast by Regions (2024-2029)
10.1.1 Global Veterinary Regenerative Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Veterinary Regenerative Medicine Forecast
10.1.3 APAC Veterinary Regenerative Medicine Forecast
10.1.4 Europe Veterinary Regenerative Medicine Forecast
10.1.5 Middle East & Africa Veterinary Regenerative Medicine Forecast
10.2 Americas Veterinary Regenerative Medicine Forecast by Country (2024-2029)
10.2.1 United States Veterinary Regenerative Medicine Market Forecast
10.2.2 Canada Veterinary Regenerative Medicine Market Forecast
10.2.3 Mexico Veterinary Regenerative Medicine Market Forecast
10.2.4 Brazil Veterinary Regenerative Medicine Market Forecast
10.3 APAC Veterinary Regenerative Medicine Forecast by Region (2024-2029)
10.3.1 China Veterinary Regenerative Medicine Market Forecast
10.3.2 Japan Veterinary Regenerative Medicine Market Forecast
10.3.3 Korea Veterinary Regenerative Medicine Market Forecast
10.3.4 Southeast Asia Veterinary Regenerative Medicine Market Forecast
10.3.5 India Veterinary Regenerative Medicine Market Forecast
10.3.6 Australia Veterinary Regenerative Medicine Market Forecast
10.4 Europe Veterinary Regenerative Medicine Forecast by Country (2024-2029)
10.4.1 Germany Veterinary Regenerative Medicine Market Forecast
10.4.2 France Veterinary Regenerative Medicine Market Forecast
10.4.3 UK Veterinary Regenerative Medicine Market Forecast
10.4.4 Italy Veterinary Regenerative Medicine Market Forecast
10.4.5 Russia Veterinary Regenerative Medicine Market Forecast
10.5 Middle East & Africa Veterinary Regenerative Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Veterinary Regenerative Medicine Market Forecast
10.5.2 South Africa Veterinary Regenerative Medicine Market Forecast
10.5.3 Israel Veterinary Regenerative Medicine Market Forecast
10.5.4 Turkey Veterinary Regenerative Medicine Market Forecast
10.5.5 GCC Countries Veterinary Regenerative Medicine Market Forecast
10.6 Global Veterinary Regenerative Medicine Forecast by Type (2024-2029)
10.7 Global Veterinary Regenerative Medicine Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 ACell Inc. (Integra LifeSciences)
11.1.1 ACell Inc. (Integra LifeSciences) Company Information
11.1.2 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product Offered
11.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 ACell Inc. (Integra LifeSciences) Main Business Overview
11.1.5 ACell Inc. (Integra LifeSciences) Latest Developments
11.2 Animal Cell Therapies, Inc.
11.2.1 Animal Cell Therapies, Inc. Company Information
11.2.2 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product Offered
11.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Animal Cell Therapies, Inc. Main Business Overview
11.2.5 Animal Cell Therapies, Inc. Latest Developments
11.3 Ardent
11.3.1 Ardent Company Information
11.3.2 Ardent Veterinary Regenerative Medicine Product Offered
11.3.3 Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Ardent Main Business Overview
11.3.5 Ardent Latest Developments
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Information
11.4.2 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product Offered
11.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim International GmbH Main Business Overview
11.4.5 Boehringer Ingelheim International GmbH Latest Developments
11.5 Cell Therapy Sciences
11.5.1 Cell Therapy Sciences Company Information
11.5.2 Cell Therapy Sciences Veterinary Regenerative Medicine Product Offered
11.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cell Therapy Sciences Main Business Overview
11.5.5 Cell Therapy Sciences Latest Developments
11.6 Dechra
11.6.1 Dechra Company Information
11.6.2 Dechra Veterinary Regenerative Medicine Product Offered
11.6.3 Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Dechra Main Business Overview
11.6.5 Dechra Latest Developments
11.7 Enso Discoveries
11.7.1 Enso Discoveries Company Information
11.7.2 Enso Discoveries Veterinary Regenerative Medicine Product Offered
11.7.3 Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Enso Discoveries Main Business Overview
11.7.5 Enso Discoveries Latest Developments
11.8 South Paws Veterinary Surgical Specialists
11.8.1 South Paws Veterinary Surgical Specialists Company Information
11.8.2 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product Offered
11.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 South Paws Veterinary Surgical Specialists Main Business Overview
11.8.5 South Paws Veterinary Surgical Specialists Latest Developments
11.9 Veterinary Specialty Center
11.9.1 Veterinary Specialty Center Company Information
11.9.2 Veterinary Specialty Center Veterinary Regenerative Medicine Product Offered
11.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Veterinary Specialty Center Main Business Overview
11.9.5 Veterinary Specialty Center Latest Developments
11.10 Vetbiologics
11.10.1 Vetbiologics Company Information
11.10.2 Vetbiologics Veterinary Regenerative Medicine Product Offered
11.10.3 Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Vetbiologics Main Business Overview
11.10.5 Vetbiologics Latest Developments
11.11 Vetherapy
11.11.1 Vetherapy Company Information
11.11.2 Vetherapy Veterinary Regenerative Medicine Product Offered
11.11.3 Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Vetherapy Main Business Overview
11.11.5 Vetherapy Latest Developments
11.12 VetStem, Inc.
11.12.1 VetStem, Inc. Company Information
11.12.2 VetStem, Inc. Veterinary Regenerative Medicine Product Offered
11.12.3 VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 VetStem, Inc. Main Business Overview
11.12.5 VetStem, Inc. Latest Developments
11.13 Zoetis
11.13.1 Zoetis Company Information
11.13.2 Zoetis Veterinary Regenerative Medicine Product Offered
11.13.3 Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Zoetis Main Business Overview
11.13.5 Zoetis Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Veterinary Regenerative Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Platelet-Rich Plasma (PRP) Table 3. Major Players of Stem Cell Therapy Table 4. Major Players of Others Table 5. Veterinary Regenerative Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 6. Global Veterinary Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 7. Global Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 8. Veterinary Regenerative Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global Veterinary Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 10. Global Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 11. Global Veterinary Regenerative Medicine Revenue by Players (2018-2023) & ($ Millions) Table 12. Global Veterinary Regenerative Medicine Revenue Market Share by Player (2018-2023) Table 13. Veterinary Regenerative Medicine Key Players Head office and Products Offered Table 14. Veterinary Regenerative Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Veterinary Regenerative Medicine Market Size by Regions 2018-2023 & ($ Millions) Table 18. Global Veterinary Regenerative Medicine Market Size Market Share by Regions (2018-2023) Table 19. Global Veterinary Regenerative Medicine Revenue by Country/Region (2018-2023) & ($ millions) Table 20. Global Veterinary Regenerative Medicine Revenue Market Share by Country/Region (2018-2023) Table 21. Americas Veterinary Regenerative Medicine Market Size by Country (2018-2023) & ($ Millions) Table 22. Americas Veterinary Regenerative Medicine Market Size Market Share by Country (2018-2023) Table 23. Americas Veterinary Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 24. Americas Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 25. Americas Veterinary Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 26. Americas Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 27. APAC Veterinary Regenerative Medicine Market Size by Region (2018-2023) & ($ Millions) Table 28. APAC Veterinary Regenerative Medicine Market Size Market Share by Region (2018-2023) Table 29. APAC Veterinary Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 30. APAC Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 31. APAC Veterinary Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 32. APAC Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 33. Europe Veterinary Regenerative Medicine Market Size by Country (2018-2023) & ($ Millions) Table 34. Europe Veterinary Regenerative Medicine Market Size Market Share by Country (2018-2023) Table 35. Europe Veterinary Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 36. Europe Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 37. Europe Veterinary Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 38. Europe Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 39. Middle East & Africa Veterinary Regenerative Medicine Market Size by Region (2018-2023) & ($ Millions) Table 40. Middle East & Africa Veterinary Regenerative Medicine Market Size Market Share by Region (2018-2023) Table 41. Middle East & Africa Veterinary Regenerative Medicine Market Size by Type (2018-2023) & ($ Millions) Table 42. Middle East & Africa Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Table 43. Middle East & Africa Veterinary Regenerative Medicine Market Size by Application (2018-2023) & ($ Millions) Table 44. Middle East & Africa Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Table 45. Key Market Drivers & Growth Opportunities of Veterinary Regenerative Medicine Table 46. Key Market Challenges & Risks of Veterinary Regenerative Medicine Table 47. Key Industry Trends of Veterinary Regenerative Medicine Table 48. Global Veterinary Regenerative Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 49. Global Veterinary Regenerative Medicine Market Size Market Share Forecast by Regions (2024-2029) Table 50. Global Veterinary Regenerative Medicine Market Size Forecast by Type (2024-2029) & ($ Millions) Table 51. Global Veterinary Regenerative Medicine Market Size Forecast by Application (2024-2029) & ($ Millions) Table 52. ACell Inc. (Integra LifeSciences) Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 53. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product Offered Table 54. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 55. ACell Inc. (Integra LifeSciences) Main Business Table 56. ACell Inc. (Integra LifeSciences) Latest Developments Table 57. Animal Cell Therapies, Inc. Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 58. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product Offered Table 59. Animal Cell Therapies, Inc. Main Business Table 60. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 61. Animal Cell Therapies, Inc. Latest Developments Table 62. Ardent Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 63. Ardent Veterinary Regenerative Medicine Product Offered Table 64. Ardent Main Business Table 65. Ardent Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 66. Ardent Latest Developments Table 67. Boehringer Ingelheim International GmbH Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 68. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product Offered Table 69. Boehringer Ingelheim International GmbH Main Business Table 70. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 71. Boehringer Ingelheim International GmbH Latest Developments Table 72. Cell Therapy Sciences Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 73. Cell Therapy Sciences Veterinary Regenerative Medicine Product Offered Table 74. Cell Therapy Sciences Main Business Table 75. Cell Therapy Sciences Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 76. Cell Therapy Sciences Latest Developments Table 77. Dechra Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 78. Dechra Veterinary Regenerative Medicine Product Offered Table 79. Dechra Main Business Table 80. Dechra Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 81. Dechra Latest Developments Table 82. Enso Discoveries Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 83. Enso Discoveries Veterinary Regenerative Medicine Product Offered Table 84. Enso Discoveries Main Business Table 85. Enso Discoveries Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 86. Enso Discoveries Latest Developments Table 87. South Paws Veterinary Surgical Specialists Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 88. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product Offered Table 89. South Paws Veterinary Surgical Specialists Main Business Table 90. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 91. South Paws Veterinary Surgical Specialists Latest Developments Table 92. Veterinary Specialty Center Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 93. Veterinary Specialty Center Veterinary Regenerative Medicine Product Offered Table 94. Veterinary Specialty Center Main Business Table 95. Veterinary Specialty Center Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 96. Veterinary Specialty Center Latest Developments Table 97. Vetbiologics Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 98. Vetbiologics Veterinary Regenerative Medicine Product Offered Table 99. Vetbiologics Main Business Table 100. Vetbiologics Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 101. Vetbiologics Latest Developments Table 102. Vetherapy Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 103. Vetherapy Veterinary Regenerative Medicine Product Offered Table 104. Vetherapy Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 105. Vetherapy Main Business Table 106. Vetherapy Latest Developments Table 107. VetStem, Inc. Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 108. VetStem, Inc. Veterinary Regenerative Medicine Product Offered Table 109. VetStem, Inc. Main Business Table 110. VetStem, Inc. Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 111. VetStem, Inc. Latest Developments Table 112. Zoetis Details, Company Type, Veterinary Regenerative Medicine Area Served and Its Competitors Table 113. Zoetis Veterinary Regenerative Medicine Product Offered Table 114. Zoetis Main Business Table 115. Zoetis Veterinary Regenerative Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 116. Zoetis Latest Developments List of Figures Figure 1. Veterinary Regenerative Medicine Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Veterinary Regenerative Medicine Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Veterinary Regenerative Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Veterinary Regenerative Medicine Sales Market Share by Country/Region (2022) Figure 8. Veterinary Regenerative Medicine Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Veterinary Regenerative Medicine Market Size Market Share by Type in 2022 Figure 10. Veterinary Regenerative Medicine in Veterinary Hospitals/Clinics Figure 11. Global Veterinary Regenerative Medicine Market: Veterinary Hospitals/Clinics (2018-2023) & ($ Millions) Figure 12. Veterinary Regenerative Medicine in Veterinary Research Institutes Figure 13. Global Veterinary Regenerative Medicine Market: Veterinary Research Institutes (2018-2023) & ($ Millions) Figure 14. Global Veterinary Regenerative Medicine Market Size Market Share by Application in 2022 Figure 15. Global Veterinary Regenerative Medicine Revenue Market Share by Player in 2022 Figure 16. Global Veterinary Regenerative Medicine Market Size Market Share by Regions (2018-2023) Figure 17. Americas Veterinary Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 18. APAC Veterinary Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 19. Europe Veterinary Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 20. Middle East & Africa Veterinary Regenerative Medicine Market Size 2018-2023 ($ Millions) Figure 21. Americas Veterinary Regenerative Medicine Value Market Share by Country in 2022 Figure 22. United States Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 23. Canada Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 24. Mexico Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 25. Brazil Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 26. APAC Veterinary Regenerative Medicine Market Size Market Share by Region in 2022 Figure 27. APAC Veterinary Regenerative Medicine Market Size Market Share by Type in 2022 Figure 28. APAC Veterinary Regenerative Medicine Market Size Market Share by Application in 2022 Figure 29. China Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 30. Japan Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 31. Korea Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 32. Southeast Asia Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 33. India Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 34. Australia Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 35. Europe Veterinary Regenerative Medicine Market Size Market Share by Country in 2022 Figure 36. Europe Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Figure 37. Europe Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Figure 38. Germany Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 39. France Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 40. UK Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 41. Italy Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 42. Russia Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 43. Middle East & Africa Veterinary Regenerative Medicine Market Size Market Share by Region (2018-2023) Figure 44. Middle East & Africa Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) Figure 45. Middle East & Africa Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) Figure 46. Egypt Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 47. South Africa Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 48. Israel Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 49. Turkey Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 50. GCC Country Veterinary Regenerative Medicine Market Size Growth 2018-2023 ($ Millions) Figure 51. Americas Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 52. APAC Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 53. Europe Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 54. Middle East & Africa Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 55. United States Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 56. Canada Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 57. Mexico Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 58. Brazil Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 59. China Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 60. Japan Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 61. Korea Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 62. Southeast Asia Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 63. India Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 64. Australia Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 65. Germany Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 66. France Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 67. UK Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 68. Italy Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 69. Russia Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 70. Spain Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 71. Egypt Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 72. South Africa Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 73. Israel Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 74. Turkey Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 75. GCC Countries Veterinary Regenerative Medicine Market Size 2024-2029 ($ Millions) Figure 76. Global Veterinary Regenerative Medicine Market Size Market Share Forecast by Type (2024-2029) Figure 77. Global Veterinary Regenerative Medicine Market Size Market Share Forecast by Application (2024-2029)
